Pregnancy Outcomes in Patients With Heart Disease in China

Hu, Jiun-Ruey; Ye, Yingxian; Lu, Anyi; Chen, Liwen; Mai, Yongjian; Huang, Guiting; Wang, Sheng

doi:10.1016/j.amjcard.2020.02.043

Cited by 12 publications

(8 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Postpartum hemorrhage refers to the amount of vaginal hemorrhage exceeding 500 mL within 24 hours after the delivery of the fetus, which is the primary cause of maternal death [ 24 ]. Studies have shown that the causes of postpartum hemorrhage in patients with pregnancy-induced hypertension are closely related to emotional changes, uterine fatigue, and improper disposal of the placenta [ 25 ]. Therefore, how to effectively prevent postpartum hemorrhage in patients with pregnancy-induced hypertension syndrome and control work is a critical issue.…”

Section: Discussionmentioning

confidence: 99%

“…(3) Satisfaction questionnaire is used, including 25 questions covering all aspects from admission to hospital. Each question adopts a 5-point scoring system: very dissatisfied is 0 points, very satisfied is 5 points, the total score is 0-100 points, very satisfied is 85-100 points, satisfied is 70-84, dissatisfied is less than 70 points, and total satisfaction is the sum of very satisfied and satisfied.…”

Section: Observation Indicatormentioning

confidence: 99%

See 1 more Smart Citation

[Retracted] To Explore the Application Effect and Value of Evidence‐Based Nursing in Patients with Pregnancy‐Induced Hypertension Syndrome

Han

Garma

Quan

et al. 2022

Contrast Media & Molecular Imaging

View full text Add to dashboard Cite

Objective. The objective is to explore the nursing methods of evidence-based nursing in preventing serious complications in patients with pregnancy-induced hypertension. Methods. A total of 80 patients with pregnancy-induced hypertension from April 2020 to April 2022 were selected and randomly divided into a control group and a research group, with 40 cases in each group. The blood pressure, Self-Efficacy Scale score, Disease Uncertainty Scale score, the incidence of maternal and infant complications, the improvement of mental state, and the patients’ satisfaction with the nursing program were observed and compared between the two groups. Results. Compared with before the intervention, the self-efficacy scores of the two groups were significantly improved, and the blood pressure, disease uncertainty score, SAS, and SDS scores were significantly decreased, and the indicators in the study group were better than those before the intervention. In the control group, the difference was statistically significant (P < 0.05). After the intervention, among the 40 patients in the study group, 10 cases (25.00%) of cesarean section were significantly lower than 19 cases (47.50%) in the control group, and the nursing work satisfaction in the study group was significantly higher than that in the control group (P < 0.05). Conclusion. The application of evidence-based nursing interventions and smart medical nursing interventions to patients with pregnancy-induced hypertension syndrome has significant effect and can effectively improve the blood pressure control effect of patients during pregnancy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Observation Indicatormentioning

confidence: 99%

[Retracted] To Explore the Application Effect and Value of Evidence‐Based Nursing in Patients with Pregnancy‐Induced Hypertension Syndrome

Han

Garma

Quan

et al. 2022

Contrast Media & Molecular Imaging

View full text Add to dashboard Cite

show abstract

“…La falla cardiaca y la arritmia fueron los desenlaces más frecuentes, con una tasa de presentación similar a la de la cohorte original del puntaje de riesgo 7,17 . La mortalidad materna y los desenlaces materno-fetales fueron discretamente mayores, esto en probable relación con la mayor proporción de gestantes con lesiones cardiacas de alto riesgo, que fueron clasificadas en los grupos de mayor riesgo (NYHA III-IV, OMSm III-IV, hipertensión pulmonar y enfermedad valvular) 18 . En nuestra cohorte de pacientes, aunque en general se logró un adecuado nivel de predicción del puntaje de riesgo CARPREG II, la mayor capacidad de discriminación se obtuvo en este último grupo de pacientes (OR: 11, IC 95%: 3.8-33; p = 0.0001).…”

Section: Discussionunclassified

Validación de los modelos de predicción de desenlaces cardiacos adversos CARPREG II (Cardiac Disease in Pregnancy) y clasificación modificada de la Organización Mundial de la Salud (OMS) en gestantes con cardiopatía

Botero-Builes¹,

Sénior²,

Velásquez-Penagos³

et al. 2022

RCCAR

View full text Add to dashboard Cite

Introducción: En gestantes con cardiopatía, los modelos de estratificación del riesgo de desenlaces adversos permiten guiar las decisiones clínicas y establecer estrategias de seguimiento y manejo de acuerdo con cada categoría. Objetivo: Validar los modelos de predicción de riesgo de desenlaces cardiacos adversos CARPREG II y OMSm en gestantes con cardiopatía. Materiales y método: Estudio de validación y comparación de dos modelos de predicción de riesgo en una cohorte prospectiva de gestantes con cardiopatía, valoradas por un equipo cardioobstétrico en un país de ingresos medios. Se evaluaron los desenlaces cardiovasculares y perinatales y se determinó la calibración y el nivel de discriminación de estas herramientas. Resultados: Entre 328 gestantes (27 años DE = 7), el 33% (n = 110) tenían cardiopatía congénita, el 30% (n = 98) arritmias, el 14% (n = 46) valvulopatías y el 9% (n = 29) miocardiopatía. Un evento cardiaco ocurrió en el 15% (10% primario y 5% secundario). La discriminación de ambos modelos fue adecuada (AUC-ROC: 0.74; IC 95%: 0.64-0.84 para CARPREG II y 0.77 para OMSm; IC 95%: 0.69-0.86). La calibración también es buena . Las variables numéricas fracción de eyección y presión sistólica de la arteria pulmonar, pueden mejorar la capacidad de predicción del CARPREG II. Conclusiones: Los modelos CARPREG II y OMSm tienen buena capacidad de predicción del riesgo de desenlaces cardiacos adversos y se ajustan a nuestras gestantes con cardiopatía.

show abstract

“…Watkins et al report that in South Africa valvular heart disease is the most common cause of cardiac disease in pregnancy, followed by cardiomyopathies and congenital heart disease. 15 Hu et al report that in China congenital heart disease is most common followed closely by rheumatic heart disease, 16 while data from India suggest that up to 69% of cardiac disease in pregnancy may be secondary to rheumatic heart disease. 17 On a worldwide basis, rheumatic heart disease is the most common form of heart disease in pregnancy and unfortunately a significant portion of these patients are diagnosed during the antenatal period often presenting with acute cardiac disease.…”

Section: Cardiac Disease In Pregnancymentioning

confidence: 99%

Focused cardiac ultrasound in pregnancy

Edwards

Anyaogu

Mezue

et al. 2023

Journal of Investigative Medicine

View full text Add to dashboard Cite

Cardiac disease in pregnancy is an important cause of maternal morbidity and mortality. In many high-income countries, acquired cardiac disease is now the largest cause of maternal mortality. Given its prevalence in low- and middle-income countries (LMICs), rheumatic heart disease is the most common cause of cardiac disease in pregnancy worldwide and is associated with poor maternal outcome. The diagnosis of cardiac disease in pregnancy is often delayed resulting in excess maternal morbidity and mortality. Maternal mortality review committees have suggested that prompt recognition and treatment of heart disease in pregnancy may improve maternal outcome. Given the similarities between symptoms of normal pregnancy and those of cardiac disease, the clinical diagnosis of heart disease in pregnancy is challenging with echocardiography being the primary diagnostic modality. Focused cardiac ultrasound (FOCUS) at the point of care provides supplemental data to the history and physical examination and has been demonstrated to permit early diagnosis and improvement in the management of cardiac disease in emergency medicine, intensive care, and anesthesia. It has also been demonstrated to be useful in surveillance for rheumatic heart disease in LMICs. The use of FOCUS may allow earlier and more accurate diagnosis of cardiac disease in pregnancy with the potential to decrease morbidity and mortality in both developed and developing countries.

show abstract

Pregnancy Outcomes in Patients With Heart Disease in China

Cited by 12 publications

References 21 publications

[Retracted] To Explore the Application Effect and Value of Evidence‐Based Nursing in Patients with Pregnancy‐Induced Hypertension Syndrome

[Retracted] To Explore the Application Effect and Value of Evidence‐Based Nursing in Patients with Pregnancy‐Induced Hypertension Syndrome

Validación de los modelos de predicción de desenlaces cardiacos adversos CARPREG II (Cardiac Disease in Pregnancy) y clasificación modificada de la Organización Mundial de la Salud (OMS) en gestantes con cardiopatía

Focused cardiac ultrasound in pregnancy

Contact Info

Product

Resources

About